929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) injection, 5 x 10 mL vials

bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) injection, 50 x 10 mL ampoules

bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, 5 x 20 mL vials

bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) injection, 5 x 20 mL ampoules

bupivacaine hydrochloride monohydrate 0.375% (75 mg/20 mL) injection, 5 x 20 mL ampoules

buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 28

buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 30

buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 7

buprenorphine 10 microgram/hour patch, 1

buprenorphine 10 microgram/hour patch, 2

buprenorphine 10 microgram/hour patch, 4

buprenorphine 100 mg/0.5 mL modified release injection, 0.5 mL syringe

buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28

buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 30

buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 7

buprenorphine 12 mg + naloxone 3 mg sublingual film, 28

buprenorphine 128 mg/0.36 mL modified release injection, 0.36 mL syringe

buprenorphine 15 microgram/hour patch, 1

buprenorphine 15 microgram/hour patch, 2

buprenorphine 15 microgram/hour patch, 4

buprenorphine 16 mg/0.32 mL modified release injection, 0.32 mL syringe

buprenorphine 16 mg tablet, 28

buprenorphine 16 mg tablet, 7

buprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe

buprenorphine 2 mg + naloxone 500 microgram sublingual film, 28

buprenorphine 2 mg + naloxone 500 microgram sublingual tablet, 28

buprenorphine 2 mg + naloxone 500 microgram sublingual tablet, 7

buprenorphine 2 mg sublingual tablet, 100

buprenorphine 2 mg sublingual tablet, 28

buprenorphine 2 mg sublingual tablet, 7

buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet, 28

buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet, 30

buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet, 7

buprenorphine 20 microgram/hour patch, 1

buprenorphine 20 microgram/hour patch, 2

buprenorphine 20 microgram/hour patch, 4

buprenorphine 200 microgram sublingual tablet, 20

buprenorphine 200 microgram sublingual tablet, 50

buprenorphine 24 mg/0.48 mL modified release injection, 0.48 mL syringe

buprenorphine 25 microgram/hour patch, 2

buprenorphine 25 microgram/hour patch, 4

buprenorphine 30 microgram/hour patch, 2

buprenorphine 30 microgram/hour patch, 4

buprenorphine 300 mg/1.5 mL modified release injection, 1.5 mL syringe

buprenorphine 300 microgram/mL injection, 5 x 1 mL ampoules

buprenorphine 32 mg/0.64 mL modified release injection, 0.64 mL syringe

buprenorphine 4 mg + naloxone 1 mg sublingual film, 28

buprenorphine 40 microgram/hour patch, 2

buprenorphine 40 microgram/hour patch, 4

buprenorphine 400 microgram sublingual tablet, 100

buprenorphine 400 microgram sublingual tablet, 28

buprenorphine 400 microgram sublingual tablet, 7

buprenorphine 5 microgram/hour patch, 1

buprenorphine 5 microgram/hour patch, 2

buprenorphine 5 microgram/hour patch, 4

buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 28

buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 30

buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 7

buprenorphine 64 mg/0.18 mL modified release injection, 0.18 mL syringe

buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet, 28

buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet, 30

buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet, 7

buprenorphine 8 mg + naloxone 2 mg sublingual film, 28

buprenorphine 8 mg + naloxone 2 mg sublingual tablet, 28

buprenorphine 8 mg + naloxone 2 mg sublingual tablet, 7

buprenorphine 8 mg/0.16 mL modified release injection, 0.16 mL syringe

buprenorphine 8 mg sublingual tablet, 100 tablets (medicinal product pack)

buprenorphine 8 mg sublingual tablet, 28

buprenorphine 8 mg sublingual tablet, 7 tablets (medicinal product pack)

buprenorphine 8 mg tablet, 28 tablets (medicinal product pack)

buprenorphine 8 mg tablet, 7

buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet, 28

buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet, 30

buprenorphine 8.6 mg + naloxone 2.1 mg sublingual tablet, 7

buprenorphine 96 mg/0.27 mL modified release injection, 0.27 mL syringe

bupropion hydrochloride 150 mg modified release tablet, 30

bupropion hydrochloride 150 mg modified release tablet, 90

naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet, 112

naltrexone hydrochloride 8 mg + bupropion hydrochloride 90 mg modified release tablet, 28

burosumab 10 mg/mL injection, 1 mL vial

burosumab 20 mg/mL injection, 1 mL vial

burosumab 30 mg/mL injection, 1 mL vial

buspirone hydrochloride 10 mg tablet, 100

buspirone hydrochloride 10 mg tablet, 50

buspirone hydrochloride 5 mg tablet, 100

buspirone hydrochloride 5 mg tablet, 50 tablets (medicinal product pack)

busulfan 2 mg tablet, 100

busulfan 60 mg/10 mL injection, 10 mL vial

busulfan 60 mg/10 mL injection, 8 x 10 mL ampoules

busulfan 60 mg/10 mL injection, 8 x 10 mL vials

butoconazole nitrate 2% vaginal cream, 1 application

salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g

butyl hydroxybenzoate 0.2% + light liquid paraffin 10% + salicylic acid 1.3% + zinc oxide 10% powder, 50 g

butyl methoxydibenzoylmethane 1.5% + octyl methoxycinnamate 7.5% + octyl salicylate 4% cream, 100 g

octyl methoxycinnamate 8.5% + butyl methoxydibenzoylmethane 2% lotion, 125 mL

octyl methoxycinnamate 4% + butyl methoxydibenzoylmethane 2.5% ointment, 15 g

homosalate 10% + octocrylene 8% + octyl salicylate 5% + butyl methoxydibenzoylmethane 4% lotion, 1 L

homosalate 10% + octocrylene 8% + octyl salicylate 5% + butyl methoxydibenzoylmethane 4% lotion, 100 g

homosalate 10% + octocrylene 8% + octyl salicylate 5% + butyl methoxydibenzoylmethane 4% lotion, 125 g

homosalate 10% + octocrylene 8% + octyl salicylate 5% + butyl methoxydibenzoylmethane 4% lotion, 200 g

homosalate 10% + octocrylene 8% + octyl salicylate 5% + butyl methoxydibenzoylmethane 4% lotion, 50 g

Start Previous Page 31 of 160 Next End

Reference Sets

Reference set descriptor